Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aeron C Hurt

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Antiviral Research|May 30, 2015
Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infectionJacqueline Panozzo, Ding Yuan Oh, Kenneth Margo, et al.
Virus Research|May 28, 2004
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugsAeron C Hurt, Jennifer L McKimm-Breschkin, Mandy McDonald, et al.
Plos One|May 30, 2020
Sequencing B cell receptors from ferrets (Mustela putorius furo)Julius Wong, Celeste M Tai, Aeron C Hurt, et al.
Veterinary Microbiology|July 9, 2019
A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivirSadhana S Kode, Shailesh D Pawar, Deeksha S Tare, et al.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from AustraliaAeron C Hurt, Ian G Barr, Christopher J Durrant, et al.
Antiviral Research|February 24, 2020
Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapyEdin J Mifsud, Danielle Tilmanis, Ding Yuan Oh, et al.
Antiviral Research|October 6, 2009
Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplificationMegan C Steain, Dominic E Dwyer, Aeron C Hurt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 27, 2015
Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoringKaren Little, Sook-Kwan Leang, Jeff Butler, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patientAeron C Hurt, Pina Iannello, Kim Jachno, et al.
Influenza and Other Respiratory Viruses|April 5, 2013
Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patientAeron C Hurt, Sook Kwan Leang, Karin Tiedemann, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Antiviral Research|May 30, 2015
Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infectionJacqueline Panozzo, Ding Yuan Oh, Kenneth Margo, et al.
Virus Research|May 28, 2004
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugsAeron C Hurt, Jennifer L McKimm-Breschkin, Mandy McDonald, et al.
Plos One|May 30, 2020
Sequencing B cell receptors from ferrets (Mustela putorius furo)Julius Wong, Celeste M Tai, Aeron C Hurt, et al.
Veterinary Microbiology|July 9, 2019
A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivirSadhana S Kode, Shailesh D Pawar, Deeksha S Tare, et al.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from AustraliaAeron C Hurt, Ian G Barr, Christopher J Durrant, et al.
Antiviral Research|February 24, 2020
Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapyEdin J Mifsud, Danielle Tilmanis, Ding Yuan Oh, et al.
Antiviral Research|October 6, 2009
Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplificationMegan C Steain, Dominic E Dwyer, Aeron C Hurt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 27, 2015
Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoringKaren Little, Sook-Kwan Leang, Jeff Butler, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patientAeron C Hurt, Pina Iannello, Kim Jachno, et al.
Influenza and Other Respiratory Viruses|April 5, 2013
Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patientAeron C Hurt, Sook Kwan Leang, Karin Tiedemann, et al.
Pageof 15